Tearsheet

Celsius (CELH)

Market Price (10/29/2025): $61.79 | Market Cap: $15.9 Bil
Sector: Consumer Staples | Industry: Soft Drinks & Non-alcoholic Beverages

Celsius (CELH)

Market Price (10/29/2025): $61.79
Market Cap: $15.9 Bil
Sector: Consumer Staples
Industry: Soft Drinks & Non-alcoholic Beverages

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 12%	Trading close to highs Dist 52W High is -4.6%	Expensive valuation multiples P/SPrice/Sales ratio is 9.6x, P/EBITPrice/EBIT or Price/(Operating Income) ratio is 90x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 68x, P/EPrice/Earnings or Price/(Net Income) is 121x
1	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 14%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 13%	Weak multi-year price returns 2Y Excs Rtn is -54%	Valuation getting more expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 57%
2			Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.7%

0	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 12%
1	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 14%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 13%
2	Trading close to highs Dist 52W High is -4.6%
3	Weak multi-year price returns 2Y Excs Rtn is -54%
4	Expensive valuation multiples P/SPrice/Sales ratio is 9.6x, P/EBITPrice/EBIT or Price/(Operating Income) ratio is 90x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 68x, P/EPrice/Earnings or Price/(Net Income) is 121x
5	Valuation getting more expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 57%
6	Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.7%

Market Valuation & Key Metrics

Valuation
Key Metrics

	10/29/25	2024	2023	2022	2021
Share Price CYE	$61.79	$26.34	$54.52	$34.68	$24.86
Market Cap CYE ($ Bil)	15.9	6.2	12.6	7.9	5.5
Total Debt ($ Bil)	0.9	0.0	0.0	0.0	0.0
Total Cash ($ Bil)	0.6	0.9	0.8	0.6	0.0
Enterprise Value ($ Bil)	16.2	6.2	12.6	7.9	5.5
Valuation Ratios
P/S TTM	9.6	4.5	9.6	12.0	17.5
P/EBIT TTM	89.5	39.5	47.2	-49.9	-1358.2
P/E TTM	120.9	42.4	55.5	-42.0	1397.5
Sector Ratios
P/S TTM (Sector)	0.9	0.9	0.9	0.9	1.5
P/EBIT TTM (Sector)	8.0	8.9	10.3	9.8	11.9
P/E TTM (Sector)	12.1	12.2	13.4	12.8	16.3

	10/29/25	2024	2023
Share Price CYE	$61.79	$26.34	$54.52
Market Cap CYE ($ Bil)	15.9	6.2	12.6
Total Debt ($ Bil)	0.9	0.0	0.0
Total Cash ($ Bil)	0.6	0.9	0.8
Enterprise Value ($ Bil)	16.2	6.2	12.6
Valuation Ratios
P/S TTM	9.6	4.5	9.6
P/EBIT TTM	89.5	39.5	47.2
P/E TTM	120.9	42.4	55.5
Sector Ratios
P/S TTM (Sector)	0.9	0.9	0.9
P/EBIT TTM (Sector)	8.0	8.9	10.3
P/E TTM (Sector)	12.1	12.2	13.4

	CELH	S&P 500
REVENUE GROWTH	VERY GOOD
Rev LTM ($ Bil)	1.7
Rev Chg Q	83.9%	6.4%
Rev Chg LTM	11.9%	5.3%
Rev Chg 3Y Avg	54.7%	5.4%
PROFITABILITY	FAIR
Op Inc LTM ($ Bil)	0.2
CFO LTM ($ Bil)	0.2
Net Inc LTM ($ Bil)	0.1
Op Mgn LTM	10.4%	18.7%
CFO/Rev LTM	14.1%	20.5%
Net Inc Mgn	7.9%	12.7%
VALUATION	VERY HIGH
P/S	9.6	3.3
P/CFO	67.6	16.1
P/FCF	75.5	21.1
P/E	120.9	24.1
STABILITY	VERY GOOD
Debt/Equity	0.05	0.21
Cash/Assets	0.16	0.07

CELH Stock

Return (1M):

Factor Drivers of Stock Movement

The 30.5% change in CELH stock from 7/29/2025 to 10/28/2025 was primarily driven by a 25.4% change in the company's Total Revenues ($ Mil).

	7292025	10282025	Change
Stock Price ($)	47.44	61.90	30.48%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	1329.20	1666.48	25.37%
Net Income Margin (%)	8.40%	7.91%	-5.90%
P/E Multiple	99.90	121.09	21.21%
Shares Outstanding (Mil)	235.19	257.75	-9.59%
Cumulative Contribution			29.28%

LTM = Last Twelve Months as of date shown

The 74.6% change in CELH stock from 4/29/2025 to 10/28/2025 was primarily driven by a 110.8% change in the company's P/E Multiple.

	4292025	10282025	Change
Stock Price ($)	35.46	61.90	74.56%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	1355.63	1666.48	22.93%
Net Income Margin (%)	10.70%	7.91%	-26.12%
P/E Multiple	57.44	121.09	110.81%
Shares Outstanding (Mil)	235.01	257.75	-9.68%
Cumulative Contribution			72.93%

LTM = Last Twelve Months as of date shown

The 97.1% change in CELH stock from 10/28/2024 to 10/28/2025 was primarily driven by a 382.3% change in the company's P/E Multiple.

	10282024	10282025	Change
Stock Price ($)	31.40	61.90	97.13%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	1489.88	1666.48	11.85%
Net Income Margin (%)	19.58%	7.91%	-59.61%
P/E Multiple	25.11	121.09	382.33%
Shares Outstanding (Mil)	233.20	257.75	-10.53%
Cumulative Contribution			94.95%

LTM = Last Twelve Months as of date shown

The 102.5% change in CELH stock from 10/29/2022 to 10/28/2025 was primarily driven by a 242.5% change in the company's Total Revenues ($ Mil).

	10292022	10282025	Change
Stock Price ($)	30.57	61.90	102.46%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	486.57	1666.48	242.49%
Net Income Margin (%)	3.78%	7.91%	108.98%
P/E Multiple	375.94	121.09	-67.79%
Shares Outstanding (Mil)	226.35	257.75	-13.87%
Cumulative Contribution			98.57%

LTM = Last Twelve Months as of date shown

Return vs. Risk

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
CELH Return	942%	48%	40%	57%	-52%	135%	3835%
Peers Return	15%	8%	-8%	1%	-13%	13%	12%
S&P 500 Return	16%	27%	-19%	24%	23%	17%	110%
Monthly Win Rates [3]
CELH Win Rate	83%	75%	50%	50%	25%	56%
Peers Win Rate	57%	55%	47%	53%	50%	56%
S&P 500 Win Rate	58%	75%	42%	67%	75%	67%
Max Drawdowns [4]
CELH Max Drawdown	-33%	-15%	-46%	-22%	-53%	-19%
Peers Max Drawdown	-32%	-13%	-23%	-15%	-20%	-14%
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: KO, PEP, MNST, HLF, KDP. See CELH Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/28/2025 (YTD)

How Low Can It Go

Unique Key	Event	CELH	S&P 500
2022 Inflation Shock	2022 Inflation Shock
2022 Inflation Shock% Loss	% Loss	-62.5%	-25.4%
2022 Inflation Shock% Gain to Breakeven	% Gain to Breakeven	166.9%	34.1%
2022 Inflation ShockTime to Breakeven	Time to Breakeven	189 days	464 days
2020 Covid Pandemic	2020 Covid Pandemic
2020 Covid Pandemic% Loss	% Loss	-51.5%	-33.9%
2020 Covid Pandemic% Gain to Breakeven	% Gain to Breakeven	106.4%	51.3%
2020 Covid PandemicTime to Breakeven	Time to Breakeven	63 days	148 days
2018 Correction	2018 Correction
2018 Correction% Loss	% Loss	-52.8%	-19.8%
2018 Correction% Gain to Breakeven	% Gain to Breakeven	111.9%	24.7%
2018 CorrectionTime to Breakeven	Time to Breakeven	439 days	120 days
2008 Global Financial Crisis	2008 Global Financial Crisis
2008 Global Financial Crisis% Loss	% Loss	-99.3%	-56.8%
2008 Global Financial Crisis% Gain to Breakeven	% Gain to Breakeven	14100.0%	131.3%
2008 Global Financial CrisisTime to Breakeven	Time to Breakeven	466 days	1480 days

Compare to KO, PEP, MNST, HLF, KDP

In The Past

Celsius's stock fell -62.5% during the 2022 Inflation Shock from a high on 11/5/2021. A -62.5% loss requires a 166.9% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Celsius (CELH)

Business Description

Celsius Holdings, Inc. develops, processes, markets, distributes, and sells functional drinks and liquid supplements in North America, Europe, Asia, and internationally. It offers various carbonated and non-carbonated functional energy drinks under the CELSIUS Originals name; dietary supplement in carbonated flavors, including apple jack'd, orangesicle, inferno punch, cherry lime, blueberry pomegranate, strawberry dragon fruit, tangerine grapefruit, and jackfruit under the CELSIUS HEAT name; and branched-chain amino acids functional energy drink that fuels muscle recovery under the CELSIUS BCCA+ENERGY name. The company also provides CELSIUS On-the-Go, a powdered form of the active ingredients in functional energy drinks in individual On-The-Go packets and canisters; and sparkling grapefruit, cucumber lime, and orange pomegranate, as well as pineapple coconut, watermelon berry, and strawberries and cream non-carbonated functional energy drinks under the CELSIUS Sweetened. It distributes its products through direct-to-store delivery distributors and direct to retailers, including supermarkets, convenience stores, drug stores, nutritional stores, and mass merchants, as well as health clubs, spas, gyms, the military, and e-commerce websites. The company was formerly known as Vector Ventures, Inc. and changed its name to Celsius Holdings, Inc. in January 2007. Celsius Holdings, Inc. was founded in 2004 and is headquartered in Boca Raton, Florida.

Better Bets than Celsius (CELH)

	CELH	Better Performance than CELH
Metric	Value	Industry (Soft Drinks & Non-alcoholic Be)
Rev Chg LTM	11.9%	PRMB (26.3%), COCO (12.0%), BRFH (24.5%)
Rev Chg 3Y Avg	54.7%
Op Mgn LTM	10.4%	KO (31.3%), PEP (13.2%), MNST (26.9%), KDP (21.5%), COKE (13.1%)
CFO/Rev LTM	14.1%	KO (16.0%), MNST (26.8%), FIZZ (17.3%)
FCF/Rev LTM	12.7%	MNST (23.5%), FIZZ (14.4%)
Total Yield	0.8%	KO (7.1%), PEP (7.2%), MNST (2.3%), KDP (5.6%), COKE (5.9%)

	CELH	Better Performance than CELH
Metric	Value	Sector (Consumer Staples)
Rev Chg LTM	11.9%	JBS (41.6%), DLTR (13.6%), SFM (16.8%), PRMB (26.3%), ELF (18.6%)
Rev Chg 3Y Avg	54.7%	SNDL (75.6%), BHST (126.1%), LOCL (113.0%), SHOT (159.5%), BOF (261.9%)
Op Mgn LTM	10.4%	PG (24.1%), KO (31.3%), PM (37.1%), PEP (13.2%), UL (14.4%)
CFO/Rev LTM	14.1%	PG (22.3%), KO (16.0%), PM (28.8%), MO (43.8%), MNST (26.8%)
FCF/Rev LTM	12.7%	PG (17.6%), PM (25.3%), MO (43.1%), MNST (23.5%), CL (16.9%)
Total Yield	0.8%	WMT (3.5%), COST (2.2%), PG (4.7%), KO (7.1%), PM (7.3%)

	CELH	Better Performance than CELH
Metric	Value	All Other Sectors
Rev Chg LTM	11.9%	NVDA (71.6%), MSFT (14.9%), GOOGL (13.1%), META (19.4%), AVGO (28.0%)
Rev Chg 3Y Avg	54.7%	NVDA (92.0%), NU (70.1%), APO (129.8%), RKLB (58.4%), SMCI (64.7%)
Op Mgn LTM	10.4%	NVDA (58.1%), MSFT (45.6%), AAPL (31.9%), GOOGL (32.7%), AMZN (11.4%)
CFO/Rev LTM	14.1%	NVDA (46.6%), MSFT (48.3%), AAPL (26.6%), GOOGL (36.0%), AMZN (18.1%)
FCF/Rev LTM	12.7%	NVDA (43.6%), MSFT (25.4%), AAPL (23.5%), GOOGL (18.0%), META (30.7%)
Total Yield	0.8%	NVDA (1.8%), MSFT (3.1%), AAPL (2.9%), GOOGL (3.9%), AMZN (2.9%)

		Best Bets In Consumer Staples Sector
	CELH	MO	PM	MNST	PG	STZ	CL	HSY	FIZZ	SMPL	KO
What You Pay
P/E	121.1	12.1	27.0	43.0	21.1	19.3	21.5	23.9	17.0	19.2	23.2
P/EBIT	89.7	9.1	15.2	32.6	16.2	11.1	14.9	19.1	13.3	12.5	17.3
What You Get
Rev Chg Q	83.9%	0.2%	9.4%	11.1%	3.0%	-15.0%	1.0%	26.0%	0.3%	-1.8%	5.1%
Rev Chg LTM	11.9%	-0.2%	7.5%	3.7%	1.2%	-5.6%	0.1%	2.5%	0.5%	9.0%	2.8%
Rev Chg 3Y Avg	54.7%	-0.9%	8.0%	8.5%	1.8%	0.7%	4.2%	5.2%	1.7%	7.5%	4.0%
FCF/Rev 3Y Avg	13.2%	42.7%	24.9%	21.4%	18.0%	17.0%	15.4%	13.9%	13.9%	13.1%	13.9%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 8.7%, alpha of 1.4%, and sharpe of 0.5

Latest Trefis Analyses

	Title	Topic	Date
0	DASHBOARDS
1	Celsius Earnings Notes
2	Celsius Stock Jumped 14% in a Month, What Now?	Return
3	With CELH Up 10% in a Week, Is It Time to Compare It Against RCL?	Counter-Intuitive Comparisons
4	CELH's One-Week Rally Offers a Chance to Reevaluate CALM	Counter-Intuitive Comparisons
5	Day 7 of Gains Streak for Celsius Stock with 34% Return (vs. 118% YTD) [8/15/2025]	Notification
6	Day 6 of Gains Streak for Celsius Stock with 33% Return (vs. 115% YTD) [8/14/2025]	Notification
7	null
8	Better Bet Than CELH Stock: Pay Less Than Celsius To Get More From NVDA, RCL
9	Is CELH Stock Still the Best Pick Among Its Peers?
10	CELH Dip Buy Analysis
11	ARTICLES
12	Mid Cap Stocks Trading At 52-Week High		August 16th, 2025
13	CELH Stock Up 34% after 7-Day Win Streak		August 16th, 2025
14	CELH Stock Up 33% after 6-Day Win Streak		August 15th, 2025
15	Mid Cap Stocks Trading At 52-Week High		August 13th, 2025
16	Stacking Up CELH Against Its Peers – Is It Still a Buy?		August 9th, 2025

	Title
0	DASHBOARDS
1	Mid Cap Stocks Trading At 52-Week High
2	CELH Stock Up 34% after 7-Day Win Streak
3	CELH Stock Up 33% after 6-Day Win Streak
4	Mid Cap Stocks Trading At 52-Week High
5	Stacking Up CELH Against Its Peers – Is It Still a Buy?
6	ARTICLES
7	Celsius Earnings Notes
8	Celsius Stock Jumped 14% in a Month, What Now?
9	With CELH Up 10% in a Week, Is It Time to Compare It Against RCL?
10	CELH's One-Week Rally Offers a Chance to Reevaluate CALM
11	Day 7 of Gains Streak for Celsius Stock with 34% Return (vs. 118% YTD) [8/15/2025]
12	Day 6 of Gains Streak for Celsius Stock with 33% Return (vs. 115% YTD) [8/14/2025]
13	null
14	Better Bet Than CELH Stock: Pay Less Than Celsius To Get More From NVDA, RCL
15	Is CELH Stock Still the Best Pick Among Its Peers?
16	CELH Dip Buy Analysis

Trade Ideas

Select past ideas related to CELH. For more, see Trefis Trade Ideas.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
IPAR_9302025_Dip_Buyer_FCFYield	09302025	IPAR	Interparfums	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	-2.4%	-2.4%	-6.0%
TAP_9302025_Dip_Buyer_FCFYield	09302025	TAP	Molson Coors Beverage	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	0.0%	0.0%	0.0%
STZ_7312025_Monopoly_xInd_xCD_Getting_Cheaper	07312025	STZ	Constellation Brands	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-17.4%	-17.4%	-21.1%
SJM_6302025_Dip_Buyer_FCFYield	06302025	SJM	JM Smucker	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	7.8%	7.8%	0.0%
BF-B_5312025_Dip_Buyer_ValueBuy	05312025	BF-B	Brown-Forman	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-13.1%	-13.1%	-22.4%

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
IPAR_9302025_Dip_Buyer_FCFYield	09302025	IPAR	Interparfums	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	-2.4%	-2.4%	-6.0%
TAP_9302025_Dip_Buyer_FCFYield	09302025	TAP	Molson Coors Beverage	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	0.0%	0.0%	0.0%
STZ_7312025_Monopoly_xInd_xCD_Getting_Cheaper	07312025	STZ	Constellation Brands	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-17.4%	-17.4%	-21.1%
SJM_6302025_Dip_Buyer_FCFYield	06302025	SJM	JM Smucker	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	7.8%	7.8%	0.0%
BF-B_5312025_Dip_Buyer_ValueBuy	05312025	BF-B	Brown-Forman	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-13.1%	-13.1%	-22.4%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	ARQT	Arcutis Biotherapeutics	27.0%	79.1%
2	W	Wayfair	23.2%	140.3%
3	AGYS	Agilysys	22.6%	7.1%
4	WULF	TeraWulf	16.9%	181.6%
5	INBX	Inhibrx Biosciences	16.4%	344.7%
6	LEG	Leggett & Platt	15.4%	12.2%
7	UEC	Uranium Energy	14.3%	127.7%
8	REGN	Regeneron Pharmaceuticals	11.8%	-7.7%
9	GCI	Gannett	10.6%	-19.6%
10	RAPP	Rapport Therapeutics	9.4%	63.2%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	ARE	Alexandria Real Estate Equities	-19.2%	-32.3%
2	METC	Ramaco Resources	-16.9%	179.1%
3	FSUN	Firstsun Capital Bancorp	-16.5%	-16.3%
4	CVLT	CommVault Systems	-16.3%	-3.4%
5	PMI	Picard Medical	-14.7%	6328.6%
6	OLN	Olin	-12.4%	-36.2%
7	VFC	VF	-12.2%	-30.9%
8	JBLU	JetBlue Airways	-11.9%	-47.1%
9	ZBRA	Zebra Technologies	-11.7%	-29.0%
10	EG	Everest	-11.4%	-14.4%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	INBX	Inhibrx Biosciences	82.5%	344.7%
2	DYN	Dyne Therapeutics	45.0%	3.1%
3	RNA	Avidity Biosciences	42.6%	140.5%
4	LUMN	Lumen Technologies	40.2%	89.3%
5	GTX	Garrett Motion	39.2%	96.3%
6	CLB	Core Laboratories	36.8%	-4.6%
7	VICR	Vicor	36.2%	85.5%
8	MOFG	MidWestOne Financial	32.7%	32.9%
9	W	Wayfair	31.7%	140.3%
10	GLUE	Monte Rosa Therapeutics	29.6%	79.1%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	PMI	Picard Medical	-67.9%	6328.6%
2	NTLA	Intellia Therapeutics	-48.2%	19.7%
3	ITGR	Integer	-37.0%	-48.7%
4	METC	Ramaco Resources	-32.4%	179.1%
5	UAMY	United States Antimony	-26.2%	416.4%
6	OGN	Organon	-26.2%	-54.3%
7	USAR	USA Rare Earth	-24.7%	67450.3%
8	WRLD	World Acceptance	-23.9%	21.5%
9	SMPL	Simply Good Foods	-22.2%	-49.3%
10	METCB	Ramaco Resources	-20.1%	65.2%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PRAX	Praxis Precision Medicines	280.5%	159.0%
2	INBX	Inhibrx Biosciences	112.0%	344.7%
3	DYN	Dyne Therapeutics	96.4%	3.1%
4	VICR	Vicor	85.0%	85.5%
5	NVTS	Navitas Semiconductor	78.4%	259.4%
6	LUMN	Lumen Technologies	70.6%	89.3%
7	BALY	Ballys	70.4%	8.8%
8	GLUE	Monte Rosa Therapeutics	70.0%	79.1%
9	NUVB	Nuvation Bio	66.8%	101.9%
10	RNA	Avidity Biosciences	64.0%	140.5%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PMI	Picard Medical	-53.4%	6328.6%
2	OGN	Organon	-35.7%	-54.3%
3	VG	Venture Global	-34.0%
4	ITGR	Integer	-32.8%	-48.7%
5	LENZ	LENZ Therapeutics	-31.4%	6.7%
6	FLY	Firefly Aerospace	-30.3%
7	SOC	Sable Offshore	-29.7%	-43.1%
8	BULL	Webull	-27.4%
9	NAGE	Niagen Bioscience	-26.6%
10	USNA	Usana Health Sciences	-26.5%	-43.4%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	ARQT	Arcutis Biotherapeutics	27.0%	79.1%
2	W	Wayfair	23.2%	140.3%
3	AGYS	Agilysys	22.6%	7.1%
4	WULF	TeraWulf	16.9%	181.6%
5	INBX	Inhibrx Biosciences	16.4%	344.7%
6	LEG	Leggett & Platt	15.4%	12.2%
7	UEC	Uranium Energy	14.3%	127.7%
8	REGN	Regeneron Pharmaceuticals	11.8%	-7.7%
9	GCI	Gannett	10.6%	-19.6%
10	RAPP	Rapport Therapeutics	9.4%	63.2%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	ARE	Alexandria Real Estate Equities	-19.2%	-32.3%
2	METC	Ramaco Resources	-16.9%	179.1%
3	FSUN	Firstsun Capital Bancorp	-16.5%	-16.3%
4	CVLT	CommVault Systems	-16.3%	-3.4%
5	PMI	Picard Medical	-14.7%	6328.6%
6	OLN	Olin	-12.4%	-36.2%
7	VFC	VF	-12.2%	-30.9%
8	JBLU	JetBlue Airways	-11.9%	-47.1%
9	ZBRA	Zebra Technologies	-11.7%	-29.0%
10	EG	Everest	-11.4%	-14.4%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	INBX	Inhibrx Biosciences	82.5%	344.7%
2	DYN	Dyne Therapeutics	45.0%	3.1%
3	RNA	Avidity Biosciences	42.6%	140.5%
4	LUMN	Lumen Technologies	40.2%	89.3%
5	GTX	Garrett Motion	39.2%	96.3%
6	CLB	Core Laboratories	36.8%	-4.6%
7	VICR	Vicor	36.2%	85.5%
8	MOFG	MidWestOne Financial	32.7%	32.9%
9	W	Wayfair	31.7%	140.3%
10	GLUE	Monte Rosa Therapeutics	29.6%	79.1%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	PMI	Picard Medical	-67.9%	6328.6%
2	NTLA	Intellia Therapeutics	-48.2%	19.7%
3	ITGR	Integer	-37.0%	-48.7%
4	METC	Ramaco Resources	-32.4%	179.1%
5	UAMY	United States Antimony	-26.2%	416.4%
6	OGN	Organon	-26.2%	-54.3%
7	USAR	USA Rare Earth	-24.7%	67450.3%
8	WRLD	World Acceptance	-23.9%	21.5%
9	SMPL	Simply Good Foods	-22.2%	-49.3%
10	METCB	Ramaco Resources	-20.1%	65.2%

Peer Comparisons for Celsius

Financials

	CELH	KO	PEP	MNST	HLF	KDP	Median
Name	Celsius	Coca-Cola	PepsiCo	Monster .	Herbalife	Keurig D.
Mkt Price	61.90	70.16	150.12	69.32	8.11	28.85	65.61
Mkt Cap	16.0	301.9	205.5	67.6	0.8	39.2	53.4
Rev LTM	1,666	47,663	92,366	7,659	4,928	16,174	11,917
Op Inc LTM	173	14,914	12,193	2,063	489	3,475	2,769
FCF LTM	211	5,570	6,788	1,804	171	1,599	1,701
FCF 3Y Avg	185	6,384	6,645	1,552	161	1,336	1,444
CFO LTM	236	7,603	11,755	2,054	265	2,128	2,091
CFO 3Y Avg	206	8,335	11,974	1,792	287	1,855	1,824

Growth & Margins

	CELH	KO	PEP	MNST	HLF	KDP	Median
Name	Celsius	Coca-Cola	PepsiCo	Monster .	Herbalife	Keurig D.
Rev Chg LTM	11.9%	2.8%	0.5%	3.7%	-2.2%	6.8%	3.2%
Rev Chg 3Y Avg	54.7%	4.0%	3.4%	8.5%	-3.4%	5.9%	4.9%
Rev Chg Q	83.9%	5.1%	2.7%	11.1%	-1.7%	10.7%	7.9%
QoQ Delta Rev Chg LTM	25.4%	1.3%	0.7%	2.8%	-0.4%	2.6%	2.0%
Op Mgn LTM	10.4%	31.3%	13.2%	26.9%	9.9%	21.5%	17.3%
Op Mgn 3Y Avg	8.5%	29.7%	13.8%	27.1%	8.2%	21.8%	17.8%
QoQ Delta Op Mgn LTM	1.0%	0.7%	-0.3%	0.6%	1.1%	0.0%	0.6%
CFO/Rev LTM	14.1%	16.0%	12.7%	26.8%	5.4%	13.2%	13.6%
CFO/Rev 3Y Avg	14.7%	18.1%	13.0%	24.6%	5.7%	12.1%	13.8%
FCF/Rev LTM	12.7%	11.7%	7.3%	23.5%	3.5%	9.9%	10.8%
FCF/Rev 3Y Avg	13.2%	13.9%	7.2%	21.4%	3.2%	8.7%	10.9%

Valuation

	CELH	KO	PEP	MNST	HLF	KDP	Median
Name	Celsius	Coca-Cola	PepsiCo	Monster .	Herbalife	Keurig D.
Mkt Cap	16.0	301.9	205.5	67.6	0.8	39.2	53.4
P/S	9.6	6.3	2.2	8.8	0.2	2.4	4.4
P/EBIT	89.7	17.3	20.3	32.6	1.7	13.8	18.8
P/E	121.1	23.2	28.5	43.0	2.6	24.8	26.6
P/CFO	67.7	39.7	17.5	32.9	3.1	18.4	25.7
Total Yield	0.8%	7.1%	7.2%	2.3%	39.0%	5.6%	6.4%
Dividend Yield	0.0%	2.8%	3.7%	0.0%	0.0%	1.6%	0.8%
FCF Yield 3Y Avg	1.5%	2.4%	3.1%	2.7%	15.4%	3.3%	2.9%
D/E	0.1	0.2	0.0	0.0	2.8	0.4	0.1
Net D/E	0.0	0.1	0.0	-0.0	2.4	0.4	0.1

Returns

	CELH	KO	PEP	MNST	HLF	KDP	Median
Name	Celsius	Coca-Cola	PepsiCo	Monster .	Herbalife	Keurig D.
1M Rtn	13.8%	6.8%	6.9%	6.1%	-8.6%	13.1%	6.9%
3M Rtn	30.5%	1.9%	5.3%	12.9%	-14.1%	-14.0%	3.6%
6M Rtn	74.6%	-1.6%	14.1%	17.0%	14.7%	-14.4%	14.4%
12M Rtn	97.1%	8.4%	-8.2%	30.5%	16.9%	-12.2%	12.6%
3Y Rtn	102.5%	26.4%	-9.4%	48.2%	-62.3%	-20.9%	8.5%
1M Excs Rtn	5.3%	2.8%	3.7%	0.1%	-8.1%	8.9%	3.2%
3M Excs Rtn	24.7%	-5.5%	-2.2%	5.3%	-19.9%	-22.2%	-3.8%
6M Excs Rtn	50.6%	-25.5%	-9.8%	-6.9%	-9.2%	-38.3%	-9.5%
12M Excs Rtn	76.7%	-11.2%	-28.0%	11.1%	-1.2%	-33.5%	-6.2%
3Y Excs Rtn	33.2%	-46.4%	-88.2%	-25.3%	-145.0%	-100.5%	-67.3%

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021	2020	2019
Period End	6/30/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Filing Date	8/8/2025	3/3/2025	2/29/2024	3/1/2023	3/16/2022	3/11/2021	3/12/2020
Key Financials
Total Revenue	1,666	1,356	1,318	654	314	131	75
EBITDA	194	163	270	-156	-3	11	12
Operating Income	173	156	266	-158	-4	8	-1
Net Income	132	145	227	-187	4	9	10
EPS	0.38	0.46	0.79	-0.88	0.02	0.04	0.05
Growth Rates
Total Revenue Growth	11.9%	2.9%	101.7%	108.0%	140.4%	74.0%	42.9%
EBITDA Growth	-44.4%	-39.5%	272.9%	-5493.3%	-124.6%	-7.6%	212.0%
Operating Income Growth	-48.1%	-41.5%	268.8%	-3758.2%	-152.2%	640.6%	86.4%
Net Income Growth	-54.8%	-36.0%	221.1%	-4857.0%	-53.8%	-14.5%	189.0%
Margins
EBITDA Margin	11.7%	12.0%	20.5%	-23.8%	-0.9%	8.7%	16.3%
Operating Income Margin	10.4%	11.5%	20.2%	-24.1%	-1.3%	6.0%	-1.9%
Net Income Margin	7.9%	10.7%	17.2%	-28.7%	1.3%	6.5%	13.3%
Cash & Debt
Total Cash	615	890	756	614	16	43	23
Total Debt	863	20	2	1	1	1	10
Net Debt / (Cash)	248	-870	-754	-613	-15	-42	-14
Cash Flows
Net Cash from Operations	236	263	141	108	-97	3	1
Free Cash from Operations	211	240	124	100	-100	3	1
Returns to Shareholders
Dividends	0	28	27	12	-0	-0	-0
Share Repurchases	5	2	-0	-0	-0	-0	-0

$ Mil \| FY: 12/31	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3
Period End	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Filing Date	8/8/2025	5/6/2025	3/3/2025	11/6/2024	8/6/2024	5/7/2024	2/29/2024	11/7/2023	8/8/2023	5/9/2023	3/1/2023	11/9/2022
Key Financials Quarterly
Total Revenue	739	329	332	266	402	356	347	385	326	260	178	188
Ebitda	157	55	-16	-1	106	84	60	99	66	45	-32	-147
Operating Income	143	52	-18	-3	94	83	59	98	65	45	-33	-148
Net Income	100	44	-19	6	80	78	50	84	52	41	-21	-182
EPS	0.33	0.15	-0.10	-0.00	0.29	0.28	0.17	0.30	0.18	0.14	-0.13	-0.82
Key Financials TTM
Total Revenue TTM	1,666	1,329	1,356	1,371	1,490	1,414	1,318	1,149	952	780	654	580
Ebitda TTM	194	144	173	250	349	309	270	177	-68	-121	-156	-121
Operating Income TTM	173	125	156	233	334	305	266	175	-71	-123	-158	-122
Net Income TTM	132	112	145	214	292	263	227	155	-110	-153	-187	-154
Growth Rates Quarterly
Total Revenue Growth	83.9%	-7.4%	-4.4%	-30.9%	23.4%	36.8%	95.2%	104.4%	111.6%	94.9%	70.7%	98.3%
EBITDA Growth	47.7%	-35.3%	-126.8%	-101.0%	61.9%	85.7%	286.6%	167.0%	427.6%	336.4%	-1073.8%	-1757.5%
Operating Income Growth	51.7%	-37.5%	-131.4%	-103.3%	45.4%	85.2%	280.0%	166.2%	421.4%	344.0%	-1244.2%	-1703.3%
Net Income Growth	25.2%	-42.9%	-137.7%	-92.4%	54.9%	88.7%	336.1%	146.2%	462.4%	517.3%	-277.7%	-1841.1%
Margins Quarterly
EBITDA Margin	21.2%	16.6%	-4.8%	-0.4%	26.4%	23.7%	17.3%	25.6%	20.1%	17.5%	-18.1%	-78.1%
Operating Income Margin	19.3%	15.8%	-5.6%	-1.2%	23.4%	23.4%	17.0%	25.4%	19.9%	17.3%	-18.4%	-78.4%
Net Income Margin	13.5%	13.5%	-5.7%	2.4%	19.8%	21.9%	14.4%	21.8%	15.8%	15.9%	-11.9%	-96.6%
Cash & Debt
Total Cash	615	977	890	904	903	879	756	760	681	595	614	592
Total Debt	863	20	20	6	2	2	2	1	1	1	1	1
Net Debt / (Cash)	248	-958	-870	-898	-901	-878	-754	-759	-680	-594	-613	-591
Cash Flows Quarterly
FCF from Operations	44	103	76	13	40	135	5	91	59	-14	-63	129
Cash Flows TTM
FCF from Operations TTM	236	232	263	192	270	290	141	73	111	85	108	126
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	1	2	1	2	-0	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	21.0%	90.8%	-29.7%	-4.6%	138.9%	123.8%	50.3%	91.8%	45.6%	29.2%	-20.1%	-115.6%
Return on Invested Capital (ROIC) TTM
ROIC TTM	5.8%	51.0%	46.5%	83.5%	127.4%	106.0%	59.7%	40.7%	-16.8%	-24.2%	-32.2%	-23.9%

Segment Financials

Revenue by Segment

$ Mil	2024	2023	2022	2021	2020
Single Segment	1,318	654	314	131	75
Total	1,318	654	314	131	75

Net Income by Segment

$ Mil	2024	2023	2022	2021	2020
Single Segment	227	-187
Total	227	-187

Price Behavior

Price Behavior

Market Price	$61.90
Market Cap ($ Bil)	16.0
First Trading Date	02/23/2007
Distance from 52W High	-4.6%
	50 Days	200 Days
DMA Price	$59.26	$42.09
DMA Trend	up	up
Distance from DMA	4.5%	47.1%
	3M	1YR
Volatility	53.2%	60.9%
Downside Capture	-102.81	36.36
Upside Capture	65.05	96.73
Correlation (SPY)	15.6%	23.3%

CELH Betas & Captures as of 9/30/2025

	1M	2M	3M	6M	1Y	3Y
Beta	0.93	0.26	0.42	0.73	0.73	1.14
Up Beta	2.22	0.60	0.47	0.92	0.81	1.14
Down Beta	2.61	4.84	3.50	0.78	0.75	1.27
Up Capture	-61%	29%	38%	73%	90%	124%
Bmk +ve Days	13	23	35	74	144	420
Stock +ve Days	8	21	31	63	119	365
Down Capture	192%	-299%	-160%	-8%	54%	102%
Bmk -ve Days	8	19	29	52	107	330
Stock -ve Days	13	20	30	60	129	383

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date	10152025
Short Interest: Shares Quantity	15,944,532
Short Interest: % Change Since 9302025	-10.5%
Average Daily Volume	4,455,926
Days-to-Cover Short Interest	3.58
Basic Shares Quantity	257,750,000
Short % of Basic Shares	6.2%

Returns Analyses

	Title
0	Celsius Stock Jumped 14% in a Month, What Now?
1	Celsius Stock Return Comparison
2	[10/14/2021] Celsius Holdings (CELH) Stock Price Forecast: AI Forecasts CELH Stock Price To Be Around $101.10 In A Month (Up 9.3%)
3	Celsius Total Shareholder Return (TSR): 39.5% in 2022 and 178.2% 3-yr returns (above peer average)
4	Celsius Holdings (CELH) Stock Return: AI Predicts CELH Average and Excess Return After a Fall or Rise

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
8/7/2025	17.3%	31.2%	36.6%
5/6/2025	4.8%	10.1%	18.3%
2/20/2025	27.8%	1.8%	29.0%
11/6/2024	-5.3%	-15.0%	-12.1%
8/6/2024	-2.3%	-8.0%	-21.7%
11/7/2023	-1.5%	-8.2%	-13.1%
8/8/2023	20.4%	27.5%	43.2%
11/3/2022	2.6%	-9.2%	35.7%
...
SUMMARY STATS
# Positive	8	5	7
# Negative	5	8	6
Median Positive	9.8%	27.5%	35.7%
Median Negative	-5.3%	-11.3%	-12.6%
Max Positive	27.8%	41.8%	59.8%
Max Negative	-14.7%	-25.8%	-35.1%

	Forward Returns
8/7/2025	17.3%	31.2%	36.6%
5/6/2025	4.8%	10.1%	18.3%
2/20/2025	27.8%	1.8%	29.0%
11/6/2024	-5.3%	-15.0%	-12.1%
8/6/2024	-2.3%	-8.0%	-21.7%
11/7/2023	-1.5%	-8.2%	-13.1%
8/8/2023	20.4%	27.5%	43.2%
11/3/2022	2.6%	-9.2%	35.7%
8/2/2022	1.8%	-9.9%	-0.1%
5/10/2022	14.8%	41.8%	59.8%
3/1/2022	3.2%	-25.8%	-9.0%
11/12/2021	-14.7%	-21.2%	-35.1%
8/12/2021	-5.8%	-12.8%	17.5%
SUMMARY STATS
# Positive	8	5	7
# Negative	5	8	6
Median Positive	9.8%	27.5%	35.7%
Median Negative	-5.3%	-11.3%	-12.6%
Max Positive	27.8%	41.8%	59.8%
Max Negative	-14.7%	-25.8%	-35.1%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
6302025	8082025	10-Q 6/30/2025
3312025	5062025	10-Q 3/31/2025
12312024	3032025	10-K 12/31/2024
9302024	11062024	10-Q 9/30/2024
6302024	8062024	10-Q 6/30/2024
3312024	5072024	10-Q 3/31/2024
12312023	2292024	10-K 12/31/2023
9302023	11072023	10-Q 9/30/2023
6302023	8082023	10-Q 6/30/2023
3312023	5092023	10-Q 3/31/2023
12312022	3012023	10-K 12/31/2022
9302022	11092022	10-Q 9/30/2022
6302022	8092022	10-Q 6/30/2022
3312022	5102022	10-Q 3/31/2022
12312021	3162022	10-K 12/31/2021
9302021	11122021	10-Q 9/30/2021

Insider Activity

Expand for More

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	Langhans Jarrod	Chief Financial Officer	8192025	Sell	60.00	5,000	300,000	6,253,620	Form
1	Langhans Jarrod	Chief Financial Officer	8112025	Sell	51.18	5,000	255,900	5,590,238	Form
2	Fieldly John	Chief Executive Officer	8082025	Sell	51.18	143,167	7,327,287	45,827,084	Form
3	Milmoe William H.		7302025	Sell	47.00	100,000	4,700,000	842,135,190	Form
4	DeSantis Deborah		7302025	Sell	47.00	100,000	4,700,000	842,135,190	Form

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Celsius (CELH)

Market Price (10/29/2025): $61.79 | Market Cap: $15.9 BilSector: Consumer Staples | Industry: Soft Drinks & Non-alcoholic Beverages

Celsius (CELH)

Market Price (10/29/2025): $61.79Market Cap: $15.9 BilSector: Consumer StaplesIndustry: Soft Drinks & Non-alcoholic Beverages

Market Valuation & Key Metrics

CELH Stock

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

About Celsius (CELH)

Interactive Breakdown

Better Bets than Celsius (CELH)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Celsius

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (10/29/2025): $61.79 | Market Cap: $15.9 Bil
Sector: Consumer Staples | Industry: Soft Drinks & Non-alcoholic Beverages

Market Price (10/29/2025): $61.79
Market Cap: $15.9 Bil
Sector: Consumer Staples
Industry: Soft Drinks & Non-alcoholic Beverages